| scholarly article | Q13442814 |
| P50 | author | Xiao-Qing Tang | Q88128027 |
| P2093 | author name string | Ping Zhang | |
| Wei Zou | |||
| Dan Zeng | |||
| Chun-Yan Wang | |||
| Xue-Feng Yang | |||
| Yi-Li Yi | |||
| Yi-Yun Tang | |||
| P2860 | cites work | Reduction in hippocampal neurogenesis after social defeat is long-lasting and responsive to late antidepressant treatment. | Q51871270 |
| Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. | Q52483263 | ||
| The tail suspension test: a new method for screening antidepressants in mice | Q69947780 | ||
| Beta 2-microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells | Q78806350 | ||
| The contribution of failing adult hippocampal neurogenesis to psychiatric disorders | Q37125836 | ||
| CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases | Q37208032 | ||
| Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. | Q37380865 | ||
| Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: Implications for depression and antidepressant action. | Q37595989 | ||
| Depression and anxiety in late life: diagnostic insights and therapeutic options | Q37900244 | ||
| Current animal models of anxiety, anxiety disorders, and anxiolytic drugs | Q37966795 | ||
| Functions and dysfunctions of adult hippocampal neurogenesis | Q38218218 | ||
| Adult neurogenesis: bridging the gap between mice and humans | Q38239993 | ||
| Adult Neurogenesis and Psychiatric Disorders | Q38708466 | ||
| Serum proteomic profiles of depressive subtypes | Q39610291 | ||
| Anxiety- and Depression-Like States Lead to Pronounced Olfactory Deficits and Impaired Adult Neurogenesis in Mice | Q40116073 | ||
| Cell biology of antigen presentation | Q40485455 | ||
| Putting together an MHC class I molecule | Q40708680 | ||
| A review of the validity and variability of the elevated plus-maze as an animal model of anxiety | Q41052733 | ||
| The effects of chronic antidepressant treatment in an animal model of anxiety | Q42209089 | ||
| Knockdown of the glucocorticoid receptor alters functional integration of newborn neurons in the adult hippocampus and impairs fear-motivated behavior | Q42511821 | ||
| Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). | Q44957948 | ||
| Increased neurogenesis and the ectopic granule cells after intrahippocampal BDNF infusion in adult rats. | Q45310403 | ||
| Hippocampal neurogenesis dysfunction linked to depressive-like behaviors in a neuroinflammation induced model of depression | Q47433574 | ||
| Melanocortin receptors mediate leptin effects on feeding and body weight but not adipose apoptosis | Q47443200 | ||
| The diagnostic utility of elevation in cerebrospinal fluid beta 2-microglobulin in HIV-1 dementia. Multicenter AIDS Cohort Study | Q48440806 | ||
| Adult hippocampal neurogenesis is involved in anxiety-related behaviors. | Q48718504 | ||
| Adult neurogenesis in the mammalian brain: significant answers and significant questions | Q24628935 | ||
| β2-microglobulin is a systemic pro-aging factor that impairs cognitive function and neurogenesis | Q27315300 | ||
| Sparse whole-genome sequencing identifies two loci for major depressive disorder | Q28265101 | ||
| TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4-8+ T cells | Q28589574 | ||
| Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants | Q29547516 | ||
| Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus | Q29619400 | ||
| Adult neurogenesis and mental illness | Q30395004 | ||
| Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neurogenesis. | Q30493524 | ||
| A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease. | Q30977031 | ||
| Deletion of running-induced hippocampal neurogenesis by irradiation prevents development of an anxious phenotype in mice | Q33700449 | ||
| Necessity of hippocampal neurogenesis for the therapeutic action of antidepressants in adult nonhuman primates | Q33883314 | ||
| Dynamics of hippocampal neurogenesis in adult humans | Q34349399 | ||
| Quantification of cleaved beta2-microglobulin in serum from patients undergoing chronic hemodialysis | Q34418550 | ||
| Selection of suitable housekeeping genes for real-time quantitative PCR in CD4(+) lymphocytes from asthmatics with or without depression | Q34461175 | ||
| The current state of the neurogenic theory of depression and anxiety | Q34943860 | ||
| Adult hippocampal neurogenesis buffers stress responses and depressive behaviour | Q35182020 | ||
| Brain-derived neurotrophic factor and neuropsychiatric disorders | Q35847085 | ||
| Stress-Induced Anxiety- and Depressive-Like Phenotype Associated with Transient Reduction in Neurogenesis in Adult Nestin-CreERT2/Diphtheria Toxin Fragment A Transgenic Mice | Q35900185 | ||
| Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA). | Q36032426 | ||
| The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice | Q36125191 | ||
| Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test | Q36127598 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Elevated mazes as animal models of anxiety: effects of serotonergic agents | Q36777380 | ||
| Health-related quality of life, anxiety and depression in young adults with disability benefits due to childhood-onset somatic conditions | Q36794195 | ||
| Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden | Q36824922 | ||
| The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? | Q36972430 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e0198027 | |
| P577 | publication date | 2018-05-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | β2-microglobulin induces depressive- and anxiety-like behaviors in rat. | |
| P478 | volume | 13 |
Search more.